HEAL - PT. Medikaloka Hermina Tbk

Rp 0

-3.450 (0%)

JAKARTA. PT Medikaloka Hermina Tbk (HEAL) projects that revenue from patients of the National Health Insurance Program (JKN) of Health Insurance Administering Board (BPJS) will contribute 45% of its total revenue.

Aristo Setiawidjaja, Director of PT Medikaloka Hermina Tbk, assessed that with the rising BPJS premiums, the deficit suffered by BPJS will be overcome. However, about its impact on the reimbursement rate, it is still waiting for further developments.

"If the reimbursement rate is raised by BPJS, hospital revenue from BPJS patients will increase," he said as quoted by Kontan.co.id on Sunday (15/9).

Therefore, this year, the company projects that around 45% of the company's revenue will come from BPJS patients, since all of the Hermina hospitals take BPJS patients.

Regarding BPJS payments, he said that there were still delays. "It's still there, but it's not getting worse," he concluded. (AM/AR)